Established 1954
Advancing
Healthcare
Through Science
Our legacy is grounded inintegrityand reflected in the high standards we uphold across our work. We deliverqualityhealthcare solutions that improve lives, guided by apatient-firstapproach and a strong sense of responsibility to the communities we serve.
A Story of Growth and Purpose.
Established in 1954, Ferozsons Laboratories Limited is a public limited company listed on the Pakistan Stock Exchange since 1960. Over the past 70 years, the company has grown to become one of Pakistan's fastest-growing pharmaceutical companies, building a strong reputation for delivering high-quality healthcare solutions and developing leadership brands across key therapeutic areas.
Our expertise spans gastroenterology, hepatology, cardiology, and oncology — with a growing focus on endocrinology, diabetes care, and mother and child health.
Pioneering Biotech Manufacturing and Expanding Pakistan's Pharmaceutical Capabilities
In partnership with the Bagó Group of Argentina, in 2006 we established BF Biosciences Limited, a cGMP-compliant biotechnology facility dedicated exclusively to the manufacture of biological products.
In 2024, BF Biosciences Limited was successfully listed on the Pakistan Stock Exchange following a highly successful IPO. As the first and only company in Pakistan to operate a biotech manufacturing facility of this kind, we continue to strengthen the country's capabilities in advanced biopharmaceutical production.
A Breakthrough in Biotech ↗A Breakthrough in
Hepatitis Treatment Access
Through our partnership with Gilead Sciences, Ferozsons Laboratories Limited introduced Sovaldi® (sofosbuvir) in 2014 — the first direct-acting antiviral therapy for hepatitis C in Pakistan — under a dedicated patient access program.
This collaboration significantly expanded access to breakthrough treatment, helping deliver life-changing care and contributing to the cure of over 250,000 hepatitis C patients nationwide.
Learn More About Ferozsons Hepatology →Alongside expanding treatment availability, we continue to work closely with healthcare providers and medical societies to strengthen awareness of hepatic diseases, support education initiatives, and facilitate screening programs that promote early diagnosis and improved patient outcomes.
View Our Social Responsibility Initiatives ↗A broad range of
pharmaceutical solutions
Through continuous development and strategic partnerships, we offer medicines across several therapeutic areas to support modern healthcare.
More to explore
Discover how Ferozsons continues to innovate across every dimension of healthcare.